Whanin Pharm (016580) — Capital Reinvestment Ratio
Whanin Pharm (016580) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩2.38 Billion) in capital expenditures (₩419.66 Million). See net asset quality index of Whanin Pharm to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Whanin Pharm Capital Reinvestment Ratio (2009–2025)
This chart tracks Whanin Pharm's Capital Reinvestment Ratio across 14 annual periods. Check Whanin Pharm investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Whanin Pharm (2009–2025)
Year-by-year Capital Reinvestment Ratio for Whanin Pharm from 2009 to 2025. For live market cap and broader valuation context, see Whanin Pharm (016580) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | ₩9.04 Billion | ₩6.18 Billion | ▼ -51.9% |
| 2024 | 1.42x | ₩20.69 Billion | ₩29.38 Billion | ▲ +4.6% |
| 2023 | 1.36x | ₩23.20 Billion | ₩31.49 Billion | ▼ -32.0% |
| 2022 | 2.00x | ₩16.85 Billion | ₩33.65 Billion | ▲ +1507.6% |
| 2021 | 0.12x | ₩35.32 Billion | ₩4.39 Billion | ▼ -64.6% |
| 2020 | 0.35x | ₩22.75 Billion | ₩7.99 Billion | ▲ +214.5% |
| 2019 | 0.11x | ₩24.73 Billion | ₩2.76 Billion | ▼ -52.5% |
| 2018 | 0.23x | ₩17.45 Billion | ₩4.10 Billion | ▼ -71.4% |
| 2017 | 0.82x | ₩23.48 Billion | ₩19.31 Billion | ▲ +118.5% |
| 2016 | 0.38x | ₩19.82 Billion | ₩7.46 Billion | ▲ +57.1% |
| 2012 | 0.24x | ₩21.11 Billion | ₩5.06 Billion | ▲ +35.2% |
| 2011 | 0.18x | ₩15.12 Billion | ₩2.68 Billion | ▲ +0.0% |
| 2010 | 0.18x | ₩15.12 Billion | ₩2.68 Billion | ▲ +51.0% |
| 2009 | 0.12x | ₩18.61 Billion | ₩2.18 Billion | — |